DiCE Molecules

several dice falling
Biotech

DiCE Molecules: another preclinical bio rolling dice on an IPO

DiCE, a preclinical, oral therapeutics biotech, will roll its dice to Wall Street to bankroll its chances against Cosentyx, Taltx and others.
Kyle LaHucik Aug 26, 2021 9:40am
several dice falling

DiCE bags $80M to roll oral IL-17 psoriasis med into the clinic

Jan 8, 2021 10:52am
Daphne Koller

Koller's insitro snaps up Haystack Sciences

Oct 23, 2020 8:13am
Genentech Building 35

Genentech, DiCE ally to go after hard-to-drug targets

Dec 19, 2017 7:00am
Astellas

Astellas pens pact to discover drugs in X-Chem’s library

Mar 21, 2017 3:15am